![]() |
|
|
Vol. 281, Issue 2, 905-913, 1997
4
Subunit in Bovine Adrenal Chromaffin Cells: Studies using
Bromoacetylcholine, Epibatidine, Cytisine and mAb351
Division of Pharmacology, Relatively little is known about the type and number of nicotinic
acetylcholine receptors (nAChRs) that mediate secretion from adrenal
chromaffin cells. In these studies, we investigated nAChR reserve pools
and their modulation using bromoacetylcholine (brACh) and the
anti-nAChR antibody mAb35. By using brACh under acetylating conditions,
adrenal catecholamine release was reduced (IC50, ~0.3
µM). This effect was slowly reversible. Submaximal concentrations of
brACh caused shifts to the right in concentration-response curves of
approximately 4-fold, as well as decreases in
Emax values for the agonists nicotine and
epibatidine. Cytisine is a nAChR agonist (EC50, ~46 µM)
that was somewhat less efficacious than nicotine
(Emax, ~85% of 10 µM nicotine) in
adrenal chromaffin cells. Submaximal concentrations of brACh caused a
small shift to the right in the concentration-response curves for the
agonist cytisine, as well as a decrease in the
Emax value. mAb35, which causes a slowly
developing loss of nAChR-mediated secretion, produced a time-dependent
shift to the right in agonist concentration-response curves and a
reduction in Emax for nicotine and
epibatidine. mAb35 treatment produced only a reduction in the
Emax value of cytisine. Finally, we cloned
and sequenced a reverse transcription-polymerase chain reaction product
from bovine adrenal chromaffin RNA that shares a high degree of
homology with
4 nAChR subunits. Northern analysis provided evidence
for the presence of this transcript in chromaffin cell cultures.
Together, these studies support the presence of a nAChR reserve in
adrenal chromaffin cells that is down-regulated by mAb35. These studies
also support the presence of more than one nAChR population mediating
secretion and the presence of
4 nAChR subunits.
Copyright © by The American Society for Pharmacology and Experimental Therapeutics